Gestational Diabetes Increases Risk of Pregnancy-Related Liver Disease

Research indicates that gestational diabetes mellitus (GDM), a common complication during pregnancy, is associated with an increased risk of liver issues both during pregnancy and later in life.

Recent reports from Liver Disease News highlight that gestational diabetes boosts the risk of liver issues during pregnancy. This finding aligns with broader medical observations regarding the intersection of metabolic health and liver function during and after the maternal period.

Long-term Liver Health Risks

The impact of gestational diabetes may extend well beyond the duration of the pregnancy. An analysis by researchers at the National Institutes of Health (NIH) and other institutions suggests that women who experience pregnancy-related diabetes may be more likely to develop a potentially serious buildup of fat in the liver later in life.

According to the NIH analysis, researchers found that women who had gestational diabetes exhibited high levels of liver enzymes associated with this condition 9 to 16 years after their pregnancy.

Metabolic and Maternal Context

Gestational diabetes is recognized as a marker of subsequent metabolic risk. Research published on April 3, 2026, identifies GDM as a common pregnancy complication that serves as an indicator for future metabolic challenges, including the potential risk for type 2 diabetes.

The prevalence of pregnancy-specific disorders and pre-existent liver diseases is expected to increase. According to a report in The Lancet, this trend is driven by several factors, including:

• Rising rates of obesity
• Increased rates of diabetes
• Higher rates of hypertension
• Advanced maternal age
• Improved screening, diagnostics, and recognition of these conditions

Biomarkers and Birth Outcomes

Ongoing scientific inquiry is also examining how maternal liver biomarkers during different trimesters of pregnancy associate with birth weight outcomes, as noted in research published via Nature.

These findings collectively suggest that the liver is a critical focal point for monitoring women with gestational diabetes, as the condition may signal underlying or future vulnerabilities in liver health that persist long after childbirth.